Isoray Inc. (AMEX:ISR) previous close was $0.77 while the outstanding shares total 141.20M. The firm has a beta of 1.08. ISR’s shares traded lower over the last trading session, losing -2.61% on 05/25/21. The shares fell to a low of $0.75 before closing at $0.75. Intraday shares traded counted 1.03 million, which was 68.81% higher than its 30-day average trading volume of 3.29M. The stock’s Relative Strength Index (RSI) is 32.49, with weekly volatility at 4.27% and ATR at 0.05. The ISR stock’s 52-week price range has touched low of $0.35 and a $2.81 high.
Investors have identified the Medical Instruments & Supplies company Isoray Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $106.40 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Isoray Inc. (ISR) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 68.07 million total, with 1.92 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record -0.01 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on ISR sounds very interesting.
Is the stock of ISR attractive?
In related news, CEO, Woods Lori A bought 68,000 shares of the company’s stock in a transaction that recorded on Nov 30. The purchase was performed at an average price of 0.38, for a total value of 25,534. As the purchase deal closes, the Controller/Prin Fin&Acct Offic, Austin Mark John now bought 19,230 shares of the company’s stock, valued at 10,000. Also, EVP of Sales & Marketing, Krachon Michael bought 28,844 shares of the company’s stock in a deal that was recorded on Oct 22. The shares were cost at an average price of 0.52 per share, with a total market value of 14,999. Following this completion of disposal, the Chief Financial Officer, Hunt Jonathan Robert now holds 67,306 shares of the company’s stock, valued at 34,999. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.78%.